CXCL10 and tuberculosis: Furthermore, no significant difference in the positive result rate of the IP-10 mRNA release assay was detected between TB/HIV co-infected patients with different amounts of CD4+ T cells (P > 0.05), also indicating that there was no significant impact of CD4+ T cells exhaustion on the performance of the IP-10 mRNA release assay.